Condition

Age Related Macular Degeneration (10)

Diabetic Macular Edema (2)

Macular Edema (2)

Retinal Vein Occlusion (2)

Central Serous Chorioretinopathy (1)

Diabetic Retinopathy. (1)

Glaucoma (1)

Idiopathic Poplypoidal Choroidal Vasculopathy (1)

Overall Status

Completed (5)

Recruiting (3)

Terminated (1)

Unknown status (1)

Phase

phase 4 (5)

n/a (2)

phase 2 (1)

Sponsor

Unity Health Toronto (3)

University Health Network, Toronto (2)

Lawson Health Research Institute (1)

LumiThera, Inc. (1)

McMaster University (1)

Sunnybrook Health Sciences Centre (1)

University of Toronto (1)

Collaborator

Canadian National Institute for the Blind (1)

Canadian Retinal Trials Group (1)

National Eye Institute (NEI) (1)

Ontario Research Fund (1)

QLT Inc. (1)

Intervention

aflibercept (3)

ranibizumab (3)

avastin (bevacizumab) (1)

bevacizumab (1)

combination photodynamic therapy (1)

intravitreal aflibercept (1)

intravitreal ranibizumab (1)

lt-300 active (pbm) (1)

lt-300 inactive (sham) (1)

Study Documents

Intervention Type

drug (8)

device (1)

procedure (1)

Funder Type

Other (9)

Industry (1)

Study Type

Interventional (8)

Observational (2)

Age Related Macular Degeneration

Showing NaN - NaN of 10

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED